Hemodialysis access just became minimally invasive and patient friendly.
Discover the new avenue in hemodialysis access.
Avenu Medical. EndoAVF For Life.™

Introducing The Ellipsys Vascular Access System.
A minimally invasive approach to AV fistula creation.

The Ellipsys® Vascular Access System has received FDA approval in the U.S. and European CE Mark approval for the creation of an arteriovenous fistula in patients with chronic kidney disease requiring hemodialysis.

2,500,000

2.5 million hemodialysis patients worldwide

0 %

Patient population growing at 8% per year

3,400,000

3.4 million hemodialysis patients worldwide by 2020

“For vascular access, Ellipsys is a paradigm shift of the highest order.”

Thomas J. Fogarty, MD

See it in action.

Interested in more clinical data?

AV fistula creation methods have not changed in 50 years. Ellipsys can change that.

Provides a minimally invasive percutaneous AV fistula without an implant

Is a minimally invasive procedure

Utilizes upper arm AVF for hemodialysis

Is ultrasound image guided

Enables single catheter venous access

Enables intravascular sealing of the vein and artery

Leaves the vasculature at the AVF site undisturbed

Requires only regional or local anesthesia

Avoids technique-dependent vessel suturing

Contact Us

Not readable? Change text. captcha txt

Start typing and press Enter to search